Voyager Therapeutics, Inc. (VYGR)
4.44
+0.15
(+3.50%)
USD |
NASDAQ |
Dec 10, 15:48
Voyager Therapeutics EPS Diluted (Quarterly): -0.4743 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -0.5128 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.89M |
| Revenue (Quarterly) | 13.36M |
| Total Expenses (Quarterly) | 41.26M |
| Enterprise Value | 67.96M |
| Gross Profit Margin (Quarterly) | 93.03% |
| Profit Margin (Quarterly) | -208.7% |
| Earnings Yield | -48.87% |
| Normalized Earnings Yield | -48.87 |